Zequipra

Zequipra (Letrozole) is an oral aromatase inhibitor used primarily for hormone receptor-positive breast cancer in postmenopausal women. This non-steroidal medication helps reduce estrogen levels to slow tumor growth. It is also prescribed off-label for ovulation induction in fertility treatments.

Letrozole, the active ingredient in Zequipra, is commonly prescribed to treat early-stage hormone receptor-positive breast cancer in postmenopausal individuals. It works by lowering estrogen production in the body, which can help prevent cancer recurrence. Additionally, it is sometimes used off-label to stimulate ovulation in women undergoing fertility treatments due to its ability to induce egg production.

Zequipra may help reduce symptoms associated with high estrogen levels, such as breast tenderness or swelling. Some users report improved energy levels or reduced discomfort related to their condition. Individual responses vary, and effects may take time to become noticeable.

Store Zequipra at room temperature away from moisture and direct light. Keep this medication out of reach of children and pets. If you are pregnant, breastfeeding, or planning pregnancy, consult a healthcare provider before use. Report any unusual symptoms to a medical professional promptly.

Zequipra may interact with other medications that affect estrogen levels or are processed by the liver. Avoid alcohol while taking this medication, as it may increase the risk of side effects. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using.